Michael Steckel

1.6k citations
14 papers · 1.3k · 1 hit paper · h-index 7

Impact in

    • NF-κB Signaling Pathways
  • Immunology top 5%
    • Immune Response and Inflammation
    • interferon and immune responses
    • Invertebrate Immune Response Mechanisms

Papers in

    • Cancer therapeutics and mechanisms 3
    • RNA modifications and cancer 3
    • Sphingolipid Metabolism and Signaling 1
    • DNA Repair Mechanisms 1
    • Epigenetics and DNA Methylation 1
    • Cancer-related Molecular Pathways 2
    • Cytokine Signaling Pathways and Interactions 2

Michael Steckel

14 papers receiving 1.3k citations

Michael Steckel's Hit Papers

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo 2005 · 638 citations
6380+7+14Years since publication200400600

Peers

Michael Steckel
Comparison fields: 5 of 85
  • Cancer Research 460
  • Immunology 455
  • Molecular Biology 751
  • Oncology 252
  • Immunology and Allergy 23
Replace Xiao Song with:
Xiao Song China
Parameswaran Ramakrishnan United States
Xiaofei Yu United States
Nufail Khan Australia
Nami Yamada Japan
Pablo Lopez‐Bergami Argentina
Mairead Commane United States
Stéphane Gobeil Canada
Aymone Gurtner Italy
Najoua Lalaoui Australia
Michael Steckel relative to Xiao Song China Xiao Song's profile →
Citations per field
00.5×2.6×
Xiao Song · 1×
Citations per year

Countries citing papers authored by Michael Steckel

Since Specialization
Citations

This map shows the geographic impact of Michael Steckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Steckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Steckel more than expected).

Fields of papers citing papers by Michael Steckel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Steckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Steckel. The network helps show where Michael Steckel may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Steckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Steckel Line = papers co-authored together Michael Steckel links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Hit paper breakdown →
2005638
2 2012221
3 2012133
4 2005110
5 201993
6 201734
7 201928
8 20154
9 20163
10 20152
11 20181
12 20151
13 20121
14 20121

About Michael Steckel

Michael Steckel is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Organic Chemistry, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Sphingolipid Metabolism and Signaling (1 paper), DNA Repair Mechanisms (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Cancer Research (460 citations), Immunology (455 citations), Molecular Biology (751 citations), Oncology (252 citations) and Immunology and Allergy (23 citations). Michael Steckel has collaborated with scholars based in Germany, Singapore and United States. Frequent co-authors include Ki‐Young Lee, P. Nagesh Rao, Shannon T. Bailey, Jae‐Hyuck Shim, Matthew S. Hayden, Kunihiro Matsumoto, Changchun Xiao, Sankar Ghosh, Nobuyuki Tanaka and Gen Yamada. Their work appears in journals such as Cancer Research, Cell Research, Journal of Hematology & Oncology, Journal of Hepatology and EMBO Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact